Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
In a trial of patients with T2DM and a BMI of 27 kg/m2 or greater being treated with semaglutide injection for weight loss, clinically significant hypoglycemia (plasma glucose less than 54 mg/dL) was reported in 6.2% of semaglutide-treated patients versus 2.5% of placebo-treated patients
Individualized Frequency Adjustments Even though monthly shots are common, your schedule might change
Nature 559 , 103108 (2018)
[13] Handling precautions should distinguish between dry compound, concentrated stock solution, diluted working solution, contaminated consumables, and chemical waste
Semaglutide an incretin receptor agonist acting through central appetite circuits, contrasted against a peripheral enzyme-inhibition mechanism
US$ 29.75
US$ 22.08
US$ 21.99
US$ 26.09
US$ 26.77
